ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Is Magnesium the Missing Link in Your Heart Healthy Routine?

A Little Zinc Goes a Long Way

Supplementation with vitamin D associated with improved testosterone, erectile function among middle...

More evidence for calorie restriction’s longevity effect

Vitamin D deficiency increases risk of chronic headache

Wearable biosensors can flag illness, Lyme disease, risk for diabetes; low airplane oxygen

VIDEO: The Best Brain Foods That Help Increase Your Memory!

Iron (And More) For Lasting, Natural Energy

Affordable Care Act made cancer screening more accessible for millions, study finds

Metabolic syndrome increases the need for vitamin E

Print Page
Email Article

New Studies Suggest Ways to Clear Alzheimer's Amyloid Plaques

  [ 80 votes ]   [ Discuss This Article ] • March 28, 2003

Two new research findings suggest that boosting normal, protective processes in the brain might help degrade or prevent damaging protein plaques associated with Alzheimer's disease (AD). In one publication, researchers at The Salk Institute and colleagues at other institutions found that gene transfer of the enzyme neprilysin may help clear a protein that forms amyloid plaques in humans. The experiments -- in mice -- are an important step in the development of an alternative approach to controlling AD and suggest closer study of the potential for neprilysin therapy.

The findings, by Fred H. Gage, Robert A. Marr, and Inder M. Verma at The Salk Institute for Biological Studies, Eliezer Masliah at the University of California San Diego and Atish Mukherjee and Louis B. Hersh at the University of Kentucky, Lexington, are reported in the latest issue of The Journal of Neuroscience. (The Journal of Neuroscience findings are embargoed until March 25, 2003, at 5 p.m. Eastern Time. They appear in the journal issue dated March 15, 2003).

The Gage report comes on the heels of another study, reported March 3, 2003, in the online version of Nature Medicine, by Jens Husemann, Columbia University, New York, Tony Wyss-Coray, Veterans Affairs Palo Alto Health Care System and Stanford University in California, and colleagues. Husemann's group found that certain cells in the brain, called astrocytes, can degrade the beta amyloid peptide in cell cultures. While not yet tested in an animal model, the study's finding that astrocytes can be effectively mobilized at the cellular level suggests yet another possible target for potential therapies for AD.

"In recent years, we have been looking at ways to battle amyloid," says Brad Wise, Program Director, Fundamental Neuroscience, the National Institute on Aging's (NIA) Neuroscience and Neuropsychology of Aging Program. "Most studies have focused on blocking the production of proteins that form AD plaques. Both of these studies suggest how we might clear amyloid even if it does build up in the brain. These are very new ways of addressing the problem."

The Gage research was funded by the NIA, part of the National Institutes of Health, U.S. Department of Health and Human Services. Funding was also provided by the Alzheimer's Association, the Canadian Institutes of Health Research, and other funds and foundations. The Husemann study was funded by the NIA and the Alzheimer's Association.

Scientists have known for many years that amyloid plaques in the brain are a hallmark feature of AD in humans. Studies on the etiology of the disease have shown that the plaques are formed when the larger amyloid precursor protein (APP) is broken up, resulting in the formation of beta amyloid protein fragments, or abeta peptides, that clump together to form insoluble amyloid plaques in certain areas of the brain with AD. It has been hypothesized that one approach to preventing AD or delaying its clinical symptoms might be to interfere with the production of beta amyloid or, more recently, to degrade beta amyloid or its plaques.

Previous research has shown that neprilysin is reduced in areas vulnerable to plaque formation and that mice without the neprilysin gene have increased levels of beta amyloid in the brain. Test tube studies have also shown that neprilysin could help stop the production of beta amyloid.

The current experiments reported by Gage and colleagues represent the first demonstration that increased levels of neprilysin decrease the deposition of amyloid in an animal model. In this study, the team injected gene vectors carrying human neprilysin into the amyloid-containing brains of transgenic mice. The gene transfer was concentrated in two areas of the brain, the hippocampus and the frontal cortex, both areas where plaque formation occurs in humans.

At the end of the treatment, the researchers reported, introduction of the neprilysin appeared to increase degradation or reduce the growth of already existing plaques. Plaques found in areas strongly "expressing" neprilysin, near the injection sites, were found to be smaller and more compact than in other regions of the brains. In some cases, what the researchers call plaque "load" was reduced to less than half that found in comparable, untreated areas. There was also evidence that neurodegeneration, neuronal cell damage, was reduced after the neprilysin gene transfer.

"If we find a way to shift the balance between amyloid production, clearance, and degradation, I believe we can find a way to interfere with the processes involved in Alzheimer's disease," says Gage. "Further study will help define the role of neprilysin in regulating amyloid and possibly treating or preventing AD."

Astrocytes, a type of cell which supports, nourishes, and protects neurons in the brain, are found around and are in contact with AD plaques. Husemann and colleages theorized that astrocytes near the AD plaques may not only immobilize or bind to abeta peptides in the brain, but might also degrade the abeta, which they found to be the case with adult mouse astrocytes.

The team then set out to see if adult astrocytes could also "process" abeta deposits from brain tissue. They incubated adult astrocytes on brain sections of transgenic mice making human APP. After 24 hours incubation with astrocytes, the area of the hippocampus occupied by abeta was reduced by 40 percent, Husemann and colleagues found. "The findings raise the intriguing possibility that defects in astrocyte cell clearance of abeta may contribute to the formation of AD plaques," notes Husemann. "Harnessing the protective function of these cells may be a strategy for AD prevention and treatment."

Post a Comment

Featured Products From the ProHealth Store
Ultra EPA  - Fish Oil Energy NADH™ 12.5mg FibroSleep™

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products

Article Comments

Be the first to comment on this article!

Post a Comment

NAD+ Ignite with Niagen

Featured Products

Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health

Natural Remedies

Pioneer Scientists Uncover a Revolutionary Neuroprotective Supplement for Nerve Health Pioneer Scientists Uncover a Revolutionary Neuroprotective Supplement for Nerve Health
Breakthrough Form of Magnesium Enhances Memory and Cognitive Function Breakthrough Form of Magnesium Enhances Memory and Cognitive Function
Olea25 Olive Hydroxytyrosol Hits Astonishing 68,000+ ORAC Antioxidant Value Olea25 Olive Hydroxytyrosol Hits Astonishing 68,000+ ORAC Antioxidant Value
The Crucial Role CoQ10 Plays in Fibromyalgia and ME/CFS The Crucial Role CoQ10 Plays in Fibromyalgia and ME/CFS
Natural Bladder Control, Go Less and Live More Natural Bladder Control, Go Less and Live More

ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
Credit Card Processing
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map